Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia

Journal of Neurochemistry

Volumn 108, Issue 3, 2009, Pages 811-820

  Liu, Wenlan ^a   Hendren, Jill ^a   Qin, Xu Jun ^a   Shen, Jiangang ^b   Liu, Ke Jian ^a,c  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Blood brain barrier; Matrix metalloproteinases; Oxygen; Stroke

Indexed keywords

BB 1101; EVANS BLUE; GELATINASE B; OCCLUDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORPUS STRIATUM; HYPEROXIA; IMMUNOHISTOCHEMISTRY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; WESTERN BLOTTING; ZYMOGRAPHY;

RATTUS;

EID: 58149326864     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05821.x     Document Type: Article

References (30)

1. Asahi M., Wang X., Mori T., Sumii T., Jung J. C., Moskowitz M. A., Fini M. E. Lo E. H. (2001) Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724 7732.
2. Chiu E. H., Liu C. S., Tan T. Y. Chang K. C. (2006) Venturi mask adjuvant oxygen therapy in severe acute ischemic stroke. Arch. Neurol. 63, 741 744.
3. Date I., Takagi N., Takagi K., Tanonaka K., Funakoshi H., Matsumoto K., Nakamura T. Takeo S. (2006) Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels. Neurosci. Lett. 407, 141 145.
4. Fanning A. S., Mitic L. L. Anderson J. M. (1999) Transmembrane proteins in the tight junction barrier. J. Am. Soc. Nephrol. 10, 1337 1345.
5. Hawkins B. T. Davis T. P. (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57, 173 185.
6. Hawkins B. T., Lundeen T. F., Norwood K. M., Brooks H. L. Egleton R. D. (2007) Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 50, 202 211.
7. Henninger N. Fisher M. (2006) Normobaric hyperoxia - a promising approach to expand the time window for acute stroke treatment. Cerebrovasc. Dis. 21, 134 136.
8. Henninger N., Bouley J., Nelligan J. M., Sicard K. M. Fisher M. (2007) Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 27, 1632 1642.
9. Hirase T., Staddon J. M., Saitou M., Ando-Akatsuka Y., Itoh M., Furuse M., Fujimoto K., Tsukita S. Rubin L. L. (1997) Occludin as a possible determinant of tight junction permeability in endothelial cells. J. Cell Sci. 110 (Pt 14 1603 1613.
10. Kago T., Takagi N., Date I., Takenaga Y., Takagi K. Takeo S. (2006) Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries. Biochem. Biophys. Res. Commun. 339, 1197 1203.
11. Kim H. Y., Singhal A. B. Lo E. H. (2005) Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann. Neurol. 57, 571 575.
12. Lacaz-Vieira F., Jaeger M. M., Farshori P. Kachar B. (1999) Small synthetic peptides homologous to segments of the first external loop of occludin impair tight junction resealing. J. Membr. Biol. 168, 289 297.
13. Latour L. L., Kang D. W., Ezzeddine M. A., Chalela J. A. Warach S. (2004) Early blood-brain barrier disruption in human focal brain ischemia. Ann. Neurol. 56, 468 477.
14. Liu S., Shi H., Liu W., Furuichi T., Timmins G. S. Liu K. J. (2004) Interstitial pO2 in ischemic penumbra and core are differentially affected following transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 24, 343 349.
15. Liu S., Liu W., Ding W., Miyake M., Rosenberg G. A. Liu K. J. (2006) Electron paramagnetic resonance-guided normobaric hyperoxia treatment protects the brain by maintaining penumbral oxygenation in a rat model of transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 26, 1274 1284.
16. Miyamoto O. Auer R. N. (2000) Hypoxia, hyperoxia, ischemia, and brain necrosis. Neurology 54, 362 371.
17. Persidsky Y., Ramirez S. H., Haorah J. Kanmogne G. D. (2006) Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. Neuroimmune Pharmacol. 1, 223 236.
18. Pfefferkorn T. Rosenberg G. A. (2003) Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke 34, 2025 2030.
19. Reijerkerk A., Kooij G., van der Pol S. M., Khazen S., Dijkstra C. D. de Vries H. E. (2006) Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J. 20, 2550 2552.
20. Rosenberg G. A., Estrada E. Y. Dencoff J. E. (1998) Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29, 2189 2195.
21. Shin H. K., Dunn A. K., Jones P. B., Boas D. A., Lo E. H., Moskowitz M. A. Ayata C. (2007) Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. Brain 130, 1631 1642.
22. Singhal A. B., Dijkhuizen R. M., Rosen B. R. Lo E. H. (2002a) Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology 58, 945 952.
23. Singhal A. B., Wang X., Sumii T., Mori T. Lo E. H. (2002b) Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab. 22, 861 868.
24. Singhal A. B., Benner T., Roccatagliata L., Koroshetz W. J., Schaefer P. W., Lo E. H., Buonanno F. S., Gonzalez R. G. Sorensen A. G. (2005) A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 36, 797 802.
25. Sood R. R., Taheri S., Candelario-Jalil E., Estrada E. Y. Rosenberg G. A. (2008) Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain. J. Cereb. Blood Flow Metab. 28, 431 438.
26. Sumii T. Lo E. H. (2002) Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 33, 831 836.
27. Tavelin S., Hashimoto K., Malkinson J., Lazorova L., Toth I. Artursson P. (2003) A new principle for tight junction modulation based on occludin peptides. Mol. Pharmacol. 64, 1530 1540.
28. Wolburg H. Lippoldt A. (2002) Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 38, 323 337.
29. Yang Y., Estrada E. Y., Thompson J. F., Liu W. Rosenberg G. A. (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27, 697 709.
30. Yong V. W., Krekoski C. A., Forsyth P. A., Bell R. Edwards D. R. (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21, 75 80.